Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Aug 10;8(8):CD012812.
doi: 10.1002/14651858.CD012812.pub2.

Home parenteral nutrition for people with inoperable malignant bowel obstruction

Anne Marie Sowerbutts  1 , Simon Lal, Jana Sremanakova, Andrew Clamp, Chris Todd, Gordon C Jayson, Antje Teubner, Anne-Marie Raftery, Eileen J Sutton, Lisa Hardy, Sorrel Burden
Affiliations
Meta-Analysis

Home parenteral nutrition for people with inoperable malignant bowel obstruction

Anne Marie Sowerbutts et al. Cochrane Database Syst Rev. .

Abstract

Background: People with advanced ovarian or gastrointestinal cancer may develop malignant bowel obstruction (MBO). They are able to tolerate limited, if any, oral or enteral (via a tube directly into the gut) nutrition. Parenteral nutrition (PN) is the provision of macronutrients, micronutrients, electrolytes and fluid infused as an intravenous solution and provides a method for these people to receive nutrients. There are clinical and ethical arguments for and against the administration of PN to people receiving palliative care.

Objectives: To assess the effectiveness of home parenteral nutrition (HPN) in improving survival and quality of life in people with inoperable MBO.

Search methods: We searched the following electronic databases: Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 1), MEDLINE (Ovid), Embase (Ovid), BNI, CINAHL, Web of Science and NHS Economic Evaluation and Health Technology Assessment up to January 2018, ClinicalTrials.gov (http://clinicaltrials.gov/) and in the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal (http://apps.who.int/trialsearch/). In addition, we handsearched included studies and used the 'Similar articles' feature on PubMed for included articles.

Selection criteria: We included any studies with more than five participants investigating HPN in people over 16 years of age with inoperable MBO.

Data collection and analysis: We extracted the data and assessed risk of bias for each study. We entered data into Review Manager 5 and used GRADEpro to assess the quality of the evidence.

Main results: We included 13 studies with a total of 721 participants in the review. The studies were observational, 12 studies had only one relevant treatment arm and no control and for the one study with a control arm, very few details were given. The risk of bias was high and the certainty of evidence was graded as very low for all outcomes. Due to heterogeneity of data, meta-analysis was not performed and therefore the data were synthesised via a narrative summary.The evidence for benefit derived from PN was very low for survival and quality of life. All the studies measured overall survival and 636 (88%) of participants were deceased at the end of the study. However there were varying definitions of overall survival that yielded median survival intervals between 15 to 155 days (range three to 1278 days). Three studies used validated measures of quality of life. The results from assessment of quality of life were equivocal; one study reported improvements up until three months and two studies reported approximately similar numbers of participants with improvements and deterioration. Different quality of life scales were used in each of the studies and quality of life was measured at different time points. Due to the very low certainty of the evidence, we are very uncertain about the adverse events related to PN use. Adverse events were measured by nine studies and data for individual participants could be extracted from eight studies. This revealed that 32 of 260 (12%) patients developed a central venous catheter infection or were hospitalised because of complications related to PN.

Authors' conclusions: We are very uncertain whether HPN improves survival or quality of life in people with MBO as the certainty of evidence was very low for both outcomes. As the evidence base is limited and at high risk of bias, further higher-quality prospective studies are required.

PubMed Disclaimer

Conflict of interest statement

Anne Marie Sowerbutts: none known Simon Lal: none known Andrew Clamp: none known Chris Todd: none known Gordon Jayson: none known Antje Teubner: none known Anne Marie Raftery: none known Eileen J Sutton: none known Jana Sremanakova: none known Sorrel Burden:none known Lisa Hardy: none known

Figures

1
1
Study flow diagram.
2
2
'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
3
3
'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
4
4
Mean survival and standard deviations calculated from median and range (Hozo 2005) for all studies apart from Keane 2018; Pironi 1997; Soo 2008 which presented mean survival
See this image and copyright information in PMC

Comment in

References

References to studies included in this review

Abu‐Rustum 1997 {published data only}
    1. Abu‐Rustum NR, Barakat RR, Venkatraman E, Spriggs D. Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecologic Oncology 1997;64:493‐5. - PubMed
August 1991 {published data only}
    1. August DA, Thorn D, Fisher RL, Welchek CM. Home parenteral nutrition for patients with inoperable malignant bowel obstruction. Journal of Parenteral and Enteral Nutrition 1991;15:323‐7. - PubMed
Bozzetti 2002 {published data only}
    1. Bozzetti F, Cozzaglio L, Biganzoli E, Chiavenna G, Cicco M, Donati D, et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition 2002;21:281‐8. - PubMed
Chermesh 2011 {published data only}
    1. Chermesh I, Mashiach T, Amit A, Haim N, Papier I, Efergan R, et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?. Medical Oncology 2011;28:83‐8. - PubMed
Cotogni 2017 {published data only}
    1. Cotogni P, Carli L, Passera R, Amerio ML, Agnello E, Fadda M, et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Medicine 2017;6:1799‐806. - PMC - PubMed
Duerksen 2004 {published data only}
    1. Duerksen DR, Ting E, Thomson P, McCurdy K, Linscer J, Larsen‐Celhar S, et al. Is there a role for TPN in terminally ill patients with bowel obstruction?. Nutrition 2004;20:760‐3. - PubMed
Finocchiaro 2002 {published data only}
    1. Finocchiaro C, Gervasio S, Agnello E, Appiano S, Bertetto O, Ciuffreda L, et al. Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale 2002;20:98‐107.
Keane 2018 {published data only}
    1. Keane N, Fragkos K, Patel P, Bertsch F, Mehta J, Caro S, et al. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutrition and Cancer 2018;70(1):73‐82. - PubMed
King 1993 {published data only}
    1. King LA, Carson LF, Konstantinides N, House MS, Adcock LL, Prem KA, et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology 1993;51:377‐82. - PubMed
Mercadante 1995 {published data only}
    1. Mercadante S. Parenteral nutrition at home in advanced cancer patients. Journal of Pain and Symptom Management 1995;10:476‐80. - PubMed
Pironi 1997 {published data only}
    1. Pironi L, Ruggeri E, Tanneberger S, Giordani S, Pannuti F, Miglioli M. Home artificial nutrition in advanced cancer. Journal of the Royal Society of Medicine 1997;90(11):597‐603. - PMC - PubMed
Santarpia 2006 {published data only}
    1. Santarpia L, Alfonsi L, Pasanisi F, Caprio C, Scalfi L, Contaldo F. Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition 2006;22:355‐60. - PubMed
Soo 2008 {published data only}
    1. Soo I, Gramlich L. Use of parenteral nutrition in patients with advanced cancer. Applied Physiology, Nutrition, and Metabolism 2008;33:102‐6. - PubMed

References to studies excluded from this review

Bozzetti 2014 {published data only}
    1. Bozzetti F, Santarpia L, Pironi L, Thul P, Klek S, Gavazzi C, et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi‐centre observational study with prospective follow‐up of 414 patients. Annals of Oncology 2014;25:487‐93. - PubMed
Bozzetti 2015 {published data only}
    1. Bozzetti F, Cotogni P, Lo Vullo S, Pironi L, Giardiello D, Mariani L. Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition. Annals of Oncology 2015;26(11):2335‐40. - PubMed
Brard 2006 {published data only}
    1. Brard L, Weitzen S, Strubel‐Lagan SL, Swamy N, Gordinier ME, Moore RG, et al. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynecologic Oncology 2006;103:176‐80. - PubMed
Chakraborty 2011 {published data only}
    1. Chakraborty A, Selby D, Gardiner K, Myers J, Moravan V, Wright F. Malignant bowel obstruction: natural history of a heterogeneous patient population followed prospectively over two years. Journal of Pain and Symptom Management 2011;41:412‐20. - PubMed
Chen 2013 {published data only}
    1. Chen CJ, Shih SC, Wang HY, Sun FJ, Lu SC, Chu CH, et al. Clinical application of total parenteral nutrition in patients with peritoneal carcinomatosis. European Journal of Cancer Care 2013;22:468‐73. - PubMed
Chouhan 2016 {published data only}
    1. Chouhan J, Gupta R, Ensor J, Raghav K, Fogelman D, Wolff RA, et al. Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction. Cancer Medicine 2016;5:239‐47. - PMC - PubMed
Diver 2013 {published data only}
    1. Diver E, O'Connor O, Garrett L, Boruta D, Goodman A, Carmen M, et al. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Gynecologic Oncology 2013;129:332‐5. - PubMed
Fan 2007 {published data only}
    1. Fan BG. Parenteral nutrition prolongs the survival of patients associated with malignant gastrointestinal obstruction. Journal of Parenteral and Enteral Nutrition 2007;31:508‐10. - PubMed
Gemlo 1986 {published data only}
    1. Gemlo B, Rayner AA, Lewis B, Wong A, Viele CS, Ungaretti JR, et al. Home support of patients with end‐stage malignant bowel obstruction using hydration and venting gastrostomy. The American Journal of Surgery 1986;152:100‐4. - PubMed
Girke 2016 {published data only}
    1. Girke J, Seipt C, Markowski A, Luettig B, Schettler A, Momma M, et al. Quality of life and nutrition condition of patients improve under home parenteral nutrition: An exploratory study. Nutrition in Clinical Practice 2016;31:659‐65. - PubMed
Guerra 2015 {published data only}
    1. Guerra EA, Cortes‐Salgado A, Mateo‐Lobo R, Nattero L, Riveiro J, Vega‐Pinero B, et al. Role of parenteral nutrition in oncologic patients with intestinal occlusion and peritoneal carcinomatosis. Nutricion Hospitalaria 2015;32:1222‐7. - PubMed
Gupta 2015 {published data only}
    1. Gupta R, Chouhan JS, Ensor J, Fogelman DR, Epner DE, Wolff AR, et al. Role of concurrent systemic chemotherapy and total parental nutrition (TPN) for the treatment of malignant small bowel obstruction (SBO). Journal of Clinical Oncology 2015;33:1.
Hoda 2005 {published data only}
    1. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20‐year experience. Cancer 2005;103:863‐8. - PubMed
Mercadante 1995a {published data only}
    1. Mercadante S. Bowel obstruction in home‐care cancer patients: 4 years experience. Support Care Cancer 1995;3:190‐3. - PubMed
Mercadante 2015 {published data only}
    1. Mercadante S, Caruselli A, Villari P, Girelli D, Prestia G, Giarratano A. Frequency and indications of parenteral nutrition in an acute palliative care unit. Nutrition and Cancer 2015;67:1010‐3. - PubMed
Naghibi 2015 {published data only}
    1. Naghibi M, Smith TR, Elia M. A systematic review with meta‐analysis of survival, quality of life and cost‐effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clinical Nutrition 2015;34:825‐37. - PubMed
Oh 2014 {published data only}
    1. Oh SY, Jun HJ, Park SJ, Park IK, Lim GJ, Yu Y, et al. A randomized phase II study to assess the effectiveness of fluid therapy or intensive nutritional support on survival in patients with advanced cancer who cannot be nourished via enteral route. Journal of Palliative Medicine 2014;17:1266‐70. - PubMed
Pasanisi 2001 {published data only}
    1. Pasanisi F, Orban A, Scalfi L, Alfonsi L, Santarpia L, Zurlo E, et al. Predictors of survival in terminal‐cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Nutrition 2001;17:581‐4. - PubMed
Szefel 2016 {published data only}
    1. Szefel J, Kruszewski WJ, Szajewski M, Ciesielski M, Sobczak E, Czerepko M, et al. Medium‐chain triglycerides/long‐chain triglycerides versus long‐chain triglycerides in treatment of cancer patients with major body mass loss. Survival in patients with refractory cachexia. Przeglad Gastroenterologiczny 2016;11:181‐6. - PMC - PubMed
Tang 1995 {published data only}
    1. Tang E, Davis J, Silberman H. Bowel obstruction in cancer patients. Archives of Surgery 1995;130:832‐6. - PubMed
Tunca 1981 {published data only}
    1. Tunca JC. Impact of cisplatin multiagent chemotherapy and total parenteral hyperalimentation on bowel obstruction caused by ovarian cancer. Gynecologic Oncology 1981;12:219‐21. - PubMed
Vashi 2014 {published data only}
    1. Vashi PG, Dahlk S, Popiel B, Lammersfeld CA, Ireton‐Jones C, Gupta D. A longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition. BMC Cancer 2014;14:593. - PMC - PubMed
Villares 2001 {published data only}
    1. Villares JM, Gomis PM, Valero MA, Leon‐Sanz M. Home parenteral nutrition in advanced cancer patients with intestinal obstruction or dysfunction. A single‐institution experience. Rivista Italiana di Nutrizione Parenterale ed Enterale 2001;19:28‐31.
Villares 2004 {published data only}
    1. Villares JMM, Gomis PM, Valero MA, Leon‐Sanz M. Home parenteral nutrition in patients with advanced cancer: experience of a single centre over ten years. Nutricion Hospitalaria 2004;19:253‐8. - PubMed

References to ongoing studies

Dreesen 2012 {published data only}
    1. Prospective non‐interventional non‐controlled multicenter observational study to evaluate the quality of care for adult patients on HPN. Ongoing study May 2012.

Additional references

Aaronson 1993
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N J, et al. The European Organization for Research and Treatment of Cancer QLQ‐C30: a quality‐of‐life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 1993;85(5):365‐76. - PubMed
Anthony 2007
    1. Anthony T, Baron T, Mercadante S, Green S, Chi D, Cunningham J, et al. Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. Journal of Pain and Symptom Management 2007;34(1 Suppl):S49‐59. - PubMed
Bakker 1999
    1. Bakker H, Bozzetti F, Staun M, Leon‐Sanz M, Hebuterne X, Pertkiewicz M, et al. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN‐Home Artificial Nutrition Working Group. Clinical Nutrition 1999;18(3):135‐40. - PubMed
Bielawska 2017
    1. Bielawska B, Allard JP. Parenteral nutrition and intestinal failure. Nutrients 2017;9(5):E446. - PMC - PubMed
Bozzetti 2009
    1. Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M. ESPEN Guidelines on parenteral nutrition: non‐surgical oncology. Clinical Nutrition 2009;28:445‐54. - PubMed
Brandt 2017
    1. Brandt CF, Hvistendahl M, Naimi RM, Tribler S, Staun M, Brøbech P, et al. Home parenteral nutrition in adult patients with chronic intestinal failure: the evolution over 4 decades in a tertiary referral center. Journal of Parenteral and Enteral Nutrition 2017;41(7):1178‐87. - PubMed
Brett 1986
    1. Gemlo B, Rayner AA, Lewis B, Wong A, Viele CS, Ungaretti JR, et al. Home support of patients with end‐stage malignant bowel obstruction using hydration and venting gastrostomy. American Journal of Surgery 1986;152(1):100‐4. - PubMed
British Intestinal Failure Alliance 2016
    1. British Intestinal Failure Alliance. British Intestinal Failure Alliance (BIFA) position statement 2016: home parenteral nutrition. British Association of Parenteral and Enteral Nutrition 2016; Vol. http://bit.ly/2qfFEbW (accessed 18 April 2018).
Chan 2011
    1. Chan R, Webster J, Marquart L. Information interventions for orienting patients and their carers to cancer care facilities. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD008273.pub2] - DOI - PMC - PubMed
Cousins 2016
    1. Cousins SE, Tempest E, Feuer DJ. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database of Systematic Reviews 2016, Issue 1. [DOI: 10.1002/14651858.CD002764.pub2] - DOI - PMC - PubMed
Daniele 2015
    1. Daniele A, Ferrero A, Fuso L, Mineccia M, Porcellana V, Vassallo D, et al. Palliative care in patients with ovarian cancer and bowel obstruction. Supportive Care in Cancer 2015;23(11):3157‐63. - PubMed
DeBernardo 2009
    1. DeBernardo, R. Surgical management of malignant bowel obstruction: strategies toward palliation of patients with advanced cancer. Current Oncology Reports 2009;11(4):287‐92. - PubMed
Deeks 2001
    1. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. BMJ 2001;323(7306):224‐8.
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88. - PubMed
DiBaise 2007
    1. DiBaise JK, Scolapio JS. Home parenteral and enteral nutrition. Gastroenterology Clinics of North America 2007;36(1):123‐44. - PubMed
Dibb 2017
    1. Dibb M, Soop M, Teubner A, Shaffer J, Abraham A, Carlson G, et al. Survival and nutritional dependence on home parenteral nutrition: three decades of experience from a single referral centre. Clinical Nutrition 2017;36(2):570‐6. - PubMed
Ferguson 2015
    1. Ferguson HJ, Ferguson CI, Speakman J, Ismail T. Management of intestinal obstruction in advanced malignancy. Annals of Medicine and Surgery 2015;4(3):264‐70. - PMC - PubMed
GRADEpro 2015 [Computer program]
    1. Evidence Prime, Inc. GRADEpro Guideline Development Tool. Hamilton (ON): McMaster University, 2015.
Guyatt 2011
    1. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1 introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383‐94. [DOI: 10.1016/j.jclinepi.2010.04.026] - DOI - PubMed
Hardy 1998
    1. Hardy J, Ling J, Mansi J, Isaacs R, Bliss J, A'Hern R, et al. Pitfalls in placebo‐controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliative Medicine 1998;12(6):437‐42. - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analysis. BMJ 2003;357(7414):557‐60. - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Howard 1995
    1. Howard L, Ament M, Fleming CR, Shike M, Steiger E. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 1995;109(2):355‐65. - PubMed
Howard 2006
    1. Howard L. Home parenteral nutrition: survival, cost, and quality of life. Gastroenterology 2006;130(2):S52‐9. - PubMed
Hozo 2005
    1. Hozo S, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5:13. - PMC - PubMed
IBM corp 2015 [Computer program]
    1. IBM Corp. SPSS statistics for windows. version 23.0. Armonk, NY: IBM corp, 2015.
Lai 2016
    1. Lai NM, Chaiyakunapruk N, Lai NA, O'Riordan E, Pau WSC, Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter‐related infections in adults. Cochrane Database of Systematic Reviews 2016, Issue 3. [DOI: 10.1002/14651858.CD007878.pub3] - DOI - PMC - PubMed
Laval 2000
    1. Laval G, Girardier J, Lassauniere JM, Leduc B, Haond C, Schaerer, R. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?. Palliative Medicine 2000;14(1):3‐10. - PubMed
Liberati 2009
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Medicine 2009;6(7):e1000100. - PMC - PubMed
Mercadante 2007
    1. Mercadante S, Casuccio A, Mangione S. Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. Journal of Pain and Symptom Management 2007;33(2):217‐23. - PubMed
Parmar 1998
    1. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34. - PubMed
Pittiruti 2009
    1. Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M, ESPEN. ESPEN guidelines on parenteral nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clinical Nutritrion 2009;28(4):365‐77. - PubMed
Porzio 2011
    1. Porzio G, Aielli F, Verna L, Galletti B, Razavi GS, Ficorella C. Can malignant bowel obstruction in advanced cancer patients be treated at home?. Supportive Care in Cancer 2011;19(3):431‐3. - PubMed
RevMan 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Ripamonti 2008
    1. Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction. European Journal of Cancer 2008;44(8):1105‐15. - PubMed
Schünemann 2011
    1. Schünemann H, Oxman A, Vist G, Higgins J, Deeks J, Glasziou P, Guyatt G. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Smith 2016
    1. Smith T, Naghibi M. BANS report 2016. Artificial nutrition support in the UK 2005–2015. Adult home parenteral nutrition and home intravenous fluids.. http://www.bapen.org.uk/images/pdfs/reports/bans‐report‐2016.pdf (accessed 06 Feb 2018).
Società Italiana Nutrizione Umana 1996
    1. Società Italiana Nutrizione Umana. [Livelli di Assunzione Raccomandati di Energia e Nutrienti per la papolazione Italiana]. EDRA Medical Publisher Revisione, 1996.
UN 1948
    1. United Nations General Assembly. Universal Declaration of Human Rights. 1948. www.refworld.org/docid/3ae6b3712c.html (accessed 21 February 2017).
US Department of Health and Human Services, 2017
    1. US Department of Health and Human Services. Common terminology criteria for adverse events. National Cancer Institute 2017; Vol. v5.
Wanten 2011
    1. Wanten G, Calder PC, Forbes A. Managing adult patients who need home parenteral nutrition. BMJ 2011;342:d1447. - PubMed
Wilburn 2017
    1. Wilburn J, McKenna SP, Heaney A, Rouse M, Taylor M, Culkin A, et al. Development and validation of the Parenteral Nutrition Impact Questionnaire (PNIQ), a patient‐centric outcome measure for Home Parenteral Nutrition. Clinical Nutrition 2017;37:978‐83. - PubMed
Winkler 2016
    1. Winkler MF, DiMaria‐Ghalili RA, Guenter P, Resnick HE, Robinson L, Lyman B, et al. Characteristics of a cohort of home parenteral nutrition patients at the time of enrollment in the Sustain Registry. Journal of Parenteral and Enteral Nutrition 2016;40(8):1140‐9. - PubMed

References to other published versions of this review

Sowerbutts 2017
    1. Sowerbutts AM, Lal S, Clamp A, Todd C, Jayson G, Teubner A, et al. Home parenteral nutrition for people with inoperable malignant bowel obstruction. Cochrane Database of Systematic Reviews 2017, Issue 10. [DOI: 10.1002/14651858.CD012812] - DOI - PMC - PubMed

Publication types